Chemical Biology & Drug Design,
Год журнала:
2025,
Номер
105(4)
Опубликована: Апрель 1, 2025
Sirtuins,
a
class
of
NAD+
-dependent
deacetylases,
play
key
role
in
aging,
metabolism,
and
longevity.
Their
interaction
with
at
the
catalytic
site
is
crucial
for
function,
but
experimental
methods
to
map
binding
sites
are
time
consuming.
To
address
this,
we
developed
computational
method
integrating
pretrained
protein
language
models
multiwindow
convolutional
neural
networks
(CNNs).
This
captures
sequence
information
diverse
local
patterns,
achieving
state-of-the-art
performance,
AUC
0.9733
human
sirtuin
proteins
0.9701
other
NAD-dependent
deacylation
enzymes.
These
findings
offer
insights
into
sirtuins
aging
their
broader
biological
functions
while
providing
new
path
identifying
therapeutic
targets
aging-related
diseases.
Oxidative Medicine and Cellular Longevity,
Год журнала:
2023,
Номер
2023, С. 1 - 23
Опубликована: Янв. 14, 2023
Cardiotoxicity
linked
to
doxorubicin
(DOX)
is
primarily
caused
by
inflammation,
oxidative
stress,
and
apoptosis.
The
role
of
tubeimoside
I
(TBM)
in
DOX-induced
cardiotoxicity
remains
ambiguous,
despite
growing
evidence
that
it
could
reduce
apoptosis
various
diseases.
This
study
was
designed
investigate
the
TBM
uncover
underlying
mechanisms.
H9c2
cell
line
C57BL/6
mice
were
used
construct
an
vitro
vivo
model
myocardial
injury,
respectively.
We
observed
DOX
treatment
provoked
cardiomyocyte
apoptosis,
which
significantly
alleviated
administration.
Mechanistically,
attenuated
downregulation
sirtuin
3
(SIRT3),
SIRT3
inhibition
abrogated
beneficial
effects
both
vivo.
In
conclusion,
eased
increasing
expression
SIRT3,
suggesting
holds
great
promise
for
treating
cardiac
injury.
Drug Design Development and Therapy,
Год журнала:
2025,
Номер
Volume 19, С. 1067 - 1081
Опубликована: Фев. 1, 2025
Doxorubicin
(DOX),
an
anthracycline
antibiotic,
has
limited
clinical
use
due
to
its
pronounced
cardiotoxicity.
Irisin,
a
myokine
known
for
metabolic
regulation,
shown
therapeutic
effects
on
cardiovascular
disease.
This
study
investigates
the
potential
cardioprotective
function
of
irisin
in
reducing
cardiac
injury
induced
by
DOX.
In
vitro,
H9c2
cells
were
pretreated
with
(20
nM)
24
hours
before
exposure
DOX
(1
μM).
vivo,
C57BL/6
mice
administered
(5
mg/kg/week,
i.p.)
4
weeks,
reaching
cumulative
dose
20
mg/kg.
Irisin
mg/kg/
3
days,
was
both
7
days
prior
and
during
injection.Cardiac
evaluated
echocardiography,
histology
assessed
using
HE,
WGA,
Masson
staining.
Myocardial
markers
quantified
ELISA,
apoptosis
analyzed
via
TUNEL
Oxidative
stress
determined
measuring
antioxidase
activity,
MDA
GSH
levels,
DHE
staining,
while
mitochondrial
superoxide
production
MitoSOX
Red.
Mitochondrial
morphology
transmission
electron
microscopy
Seahorse
analysis,
respectively
Inflammatory
cytokines
serum
cell
supernatants.
The
role
PERK-eIF2α-ATF4
pathway
mediated
investigated
Western
blot.
Using
adeno-associated
virus
serotype-9
carrying
mouse
FNDC5
shRNA
(AAV9-shFNDC5)
further
validated
protective
DOX-induced
myocardial
injury.
reduced
dysfunction
fibrosis.
Moreover,
mitigated
oxidative
inflammation
through
inhibiting
activated
DOX,
thus
preserving
function.
While
knockdown
exacerbated
heart
activation,
which
partially
reversed
irisin.
mitigates
modulating
pathway,
highlighting
as
prospective
approach
combating
Chemical Biology & Drug Design,
Год журнала:
2025,
Номер
105(4)
Опубликована: Апрель 1, 2025
Sirtuins,
a
class
of
NAD+
-dependent
deacetylases,
play
key
role
in
aging,
metabolism,
and
longevity.
Their
interaction
with
at
the
catalytic
site
is
crucial
for
function,
but
experimental
methods
to
map
binding
sites
are
time
consuming.
To
address
this,
we
developed
computational
method
integrating
pretrained
protein
language
models
multiwindow
convolutional
neural
networks
(CNNs).
This
captures
sequence
information
diverse
local
patterns,
achieving
state-of-the-art
performance,
AUC
0.9733
human
sirtuin
proteins
0.9701
other
NAD-dependent
deacylation
enzymes.
These
findings
offer
insights
into
sirtuins
aging
their
broader
biological
functions
while
providing
new
path
identifying
therapeutic
targets
aging-related
diseases.